Annual Drug Patent Expirations for ENVARSUS+XR
Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. There are seventeen patents protecting this drug.
Drug patent litigation for ENVARSUS XR.
This drug has forty-nine patent family members in twenty-four countries.
The generic ingredient in ENVARSUS XR is tacrolimus. Additional details are available on the tacrolimus profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
